Keiichi Sumida

3.7k total citations
122 papers, 1.5k citations indexed

About

Keiichi Sumida is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Keiichi Sumida has authored 122 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Nephrology, 38 papers in Pulmonary and Respiratory Medicine and 31 papers in Molecular Biology. Recurrent topics in Keiichi Sumida's work include Renal Diseases and Glomerulopathies (39 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers) and Genetic and Kidney Cyst Diseases (22 papers). Keiichi Sumida is often cited by papers focused on Renal Diseases and Glomerulopathies (39 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers) and Genetic and Kidney Cyst Diseases (22 papers). Keiichi Sumida collaborates with scholars based in Japan, United States and Australia. Keiichi Sumida's co-authors include Yoshifumi Ubara, Noriko Hayami, Junichi Hoshino, Tatsuya Suwabe, Naoki Sawa, Kenmei Takaichi, Masayuki Yamanouchi, Eiko Hasegawa, Rikako Hiramatsu and Koki Mise and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Keiichi Sumida

119 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Sumida Japan 23 751 340 328 310 229 122 1.5k
Noriko Hayami Japan 22 660 0.9× 355 1.0× 337 1.0× 348 1.1× 252 1.1× 134 1.5k
Rikako Hiramatsu Japan 20 559 0.7× 278 0.8× 262 0.8× 285 0.9× 177 0.8× 104 1.2k
Tatsuya Suwabe Japan 25 855 1.1× 543 1.6× 501 1.5× 626 2.0× 321 1.4× 269 2.2k
Naoki Sawa Japan 25 893 1.2× 525 1.5× 523 1.6× 578 1.9× 355 1.6× 264 2.2k
Khalil El Karoui France 21 796 1.1× 328 1.0× 201 0.6× 80 0.3× 221 1.0× 58 1.6k
Amr El‐Husseini Egypt 24 657 0.9× 177 0.5× 290 0.9× 78 0.3× 248 1.1× 84 1.6k
Jingyuan Xie China 21 914 1.2× 318 0.9× 292 0.9× 91 0.3× 75 0.3× 121 1.6k
Jean–Claude Souberbielle France 24 496 0.7× 247 0.7× 194 0.6× 248 0.8× 56 0.2× 81 1.8k
Markus J. Kemper Germany 23 1.3k 1.8× 397 1.2× 259 0.8× 131 0.4× 143 0.6× 65 1.9k
Ladan Zand United States 25 1.6k 2.1× 656 1.9× 595 1.8× 91 0.3× 185 0.8× 90 2.2k

Countries citing papers authored by Keiichi Sumida

Since Specialization
Citations

This map shows the geographic impact of Keiichi Sumida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Sumida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Sumida more than expected).

Fields of papers citing papers by Keiichi Sumida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Sumida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Sumida. The network helps show where Keiichi Sumida may publish in the future.

Co-authorship network of co-authors of Keiichi Sumida

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Sumida. A scholar is included among the top collaborators of Keiichi Sumida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Sumida. Keiichi Sumida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumida, Keiichi, et al.. (2025). Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD. Clinical Journal of the American Society of Nephrology. 20(10). 1341–1351.
2.
Takahashi, Rina, Jenny I. Shen, Tiane Dai, et al.. (2025). The Association of Fibrate Use with Kidney Outcomes and Mortality. Clinical Journal of the American Society of Nephrology. 20(6). 779–787. 1 indexed citations
3.
Takahashi, Rina, Keiichi Sumida, Fridtjof Thomas, et al.. (2025). The Association of Niacin Use with Kidney Outcomes and Mortality. American Journal of Nephrology. 56(4). 457–467. 2 indexed citations
4.
Takahashi, Rina, Jenny I. Shen, Diana Tran, et al.. (2025). The Association of Antiemetics Use With Incident Chronic Kidney Disease. Journal of Renal Nutrition. 35(6). 749–755.
5.
Bohm, Clara, Paul N. Bennett, Kelly Lambert, et al.. (2023). Advancing Exercise Science for Better Health Outcomes Across the Spectrum of Chronic Kidney Disease. Journal of Renal Nutrition. 33(6). S103–S109. 4 indexed citations
6.
Sumida, Keiichi, Asami Takeda, Kengo Furuichi, et al.. (2021). Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR). Clinical and Experimental Nephrology. 26(4). 325–332. 2 indexed citations
7.
Hiramatsu, Rikako, Junichi Hoshino, Hiroki Mizuno, et al.. (2020). Denosumab for dialysis patients with osteoporosis: A cohort study. Scientific Reports. 10(1). 2496–2496. 36 indexed citations
8.
Ôshima, Yôichi, Keiichi Sumida, Masayuki Yamanouchi, et al.. (2020). Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders. Scientific Reports. 10(1). 1490–1490. 5 indexed citations
9.
Sekine, Akinari, Hiroki Mizuno, Eiko Hasegawa, et al.. (2019). Renal-Limited Thrombotic Microangiopathy due to Bevacizumab Therapy for Metastatic Colorectal Cancer: A Case Report. Case Reports in Oncology. 12(2). 391–400. 10 indexed citations
10.
Matsunami, Masatoshi, Yoshifumi Ubara, Keiichi Sumida, et al.. (2018). The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrology. 19(1). 263–263. 10 indexed citations
11.
Hoshino, Junichi, Hiroki Mizuno, Tatsuya Suwabe, et al.. (2018). Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report. Case Reports in Nephrology and Dialysis. 8(1). 62–69.
12.
Yamanouchi, Masayuki, Rikako Hiramatsu, Noriko Hayami, et al.. (2018). Preservation of renal function by intensive glycemic control. Endocrinology Diabetes and Metabolism Case Reports. 2018. 2 indexed citations
13.
Gyamlani, Geeta, Miklos Z. Molnar, Jun Lü, et al.. (2017). Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrology Dialysis Transplantation. 32(1). 157–164. 62 indexed citations
14.
Mise, Koki, Junichi Hoshino, Toshiharu Ueno, et al.. (2016). Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-D-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy–Proven Diabetic Nephropathy. Clinical Journal of the American Society of Nephrology. 11(4). 593–601. 85 indexed citations
15.
Yamanouchi, Masayuki, Yoshifumi Ubara, Aya Imafuku, et al.. (2015). Malignant Nephrosclerosis in a Patient with Familial Mediterranean Fever. Internal Medicine. 54(20). 2643–2646. 3 indexed citations
16.
Hasegawa, Jumpei, Junichi Hoshino, Tatsuya Suwabe, et al.. (2015). Characteristics of Intravascular Large B-Cell Lymphoma Limited to the Glomerular Capillaries: A Case Report. Case Reports in Nephrology and Dialysis. 5(2). 173–179. 7 indexed citations
17.
Hiramatsu, Rikako, Yoshifumi Ubara, Naoki Sawa, et al.. (2015). Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation–related membranous glomerulonephritis. Human Pathology. 50. 187–194. 18 indexed citations
18.
Suwabe, Tatsuya, Yoshifumi Ubara, Koki Mise, et al.. (2013). Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study. BMC Nephrology. 14(1). 179–179. 45 indexed citations
19.
Tsuchiya, Yoshiki, Yoshifumi Ubara, Tatsuya Suwabe, et al.. (2011). Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis. Clinical and Experimental Nephrology. 15(3). 434–437. 6 indexed citations
20.
Tsuchiya, Yoshiki, Yoshifumi Ubara, Tatsuya Suwabe, et al.. (2010). The renal cyst infection caused by Salmonella enteritidis in a patient with autosomal dominant polycystic kidney disease: how did this pathogen come into the renal cysts?. Clinical and Experimental Nephrology. 15(1). 151–153. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026